Mobilization of Mesenchymal Stem Cells During Liver Transplantation

Completed

Conditions studied: Liver Failure, Liver Neoplasm

In brief

To study if the administration of corticoid hinder or enhance the mobilization of Mesenchymal Stem Cells (MSCs) in the peripheral blood during liver transplantation and whether this affects the outcome with respect to graft versus host response.

Key facts

Study ID

NCT02557724

Run by

Rutgers, The State University of New Jersey

People needed

35

Starts

2015-09-01

Expected to finish

2017-07-01

Last updated by the study team

2018-10-16

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• • Patients 21-80 capable of providing informed consent
• ASA rating between 1-4
• Patients undergoing liver transplant or liver surgery for the first time.

You may not qualify if…

• • Patient less than 21 years of age
• Patients unwilling to consent
• If donor liver was obtained after cardiac death

Where it is running

• University Hospital — Newark, New Jersey, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.